JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB54576

Anti-Cdk6 antibody [8H4]

Be the first to review this product! Submit a review

|

(16 Publications)

Knockout Tested Mouse Monoclonal CDK6 antibody. Suitable for WB and reacts with Human samples. Cited in 16 publications. Immunogen corresponding to Recombinant Fragment Protein within Human CDK6 aa 1-100.

View Alternative Names

CDKN6, CDK6, Cyclin-dependent kinase 6, Cell division protein kinase 6, Serine/threonine-protein kinase PLSTIRE

4 Images
Western blot - Anti-Cdk6 antibody [8H4] (AB54576)
  • WB

Lab

Western blot - Anti-Cdk6 antibody [8H4] (AB54576)

Lanes 1- 2 : Merged signal (red and green). Green - ab54576 observed at 37 kDa. Red - Anti-alpha Tubulin antibody [EP1332Y] - Microtubule Marker (ab52866) observed at 50 kDa.

ab54576 was shown to react with Cdk6 in wild-type HeLa cells in western blot. Loss of signal was observed when knockout cell line ab266059 (knockout cell lysate ab257088) was used. Wild-type HeLa and Cdk6 knockout HeLa cell lysates were subjected to SDS-PAGE. Membrane was blocked for 1 hour at room temperature in 0.1% TBST with 3% non-fat dried milk. ab54576 and Anti-alpha Tubulin antibody [EP1332Y] - Microtubule Marker (ab52866) overnight at 4°C at 1 μg/ml and a 1 in 20000 dilution respectively. Blots were developed with Goat anti-Mouse IgG H&L (IRDye®800CW) preadsorbed (ab216772) and Goat Anti-Rabbit IgG H&L (IRDye®680RD) preadsorbed (ab216777) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-Cdk6 antibody [8H4] (ab54576) at 1 µg/mL

Lane 1:

Wild-type HeLa cell lysate at 20 µg

Lane 2:

Western blot - Human CDK6 knockout HeLa cell lysate (<a href='/en-us/products/cell-lysates/human-cdk6-knockout-hela-cell-lysate-ab257088'>ab257088</a>) at 20 µg

Predicted band size: 37 kDa

Observed band size: 37 kDa

false

Western blot - Anti-Cdk6 antibody [8H4] (AB54576)
  • WB

Unknown

Western blot - Anti-Cdk6 antibody [8H4] (AB54576)

Cdk6 antibody (ab54576) at 1ug/lane + Jurkat cell lysate at 25ug/lane.

This image was generated using the ascites version of the product.

All lanes:

Western blot - Anti-Cdk6 antibody [8H4] (ab54576)

Predicted band size: 37 kDa

false

Western blot - Anti-Cdk6 antibody [8H4] (AB54576)
  • WB

Lab

Western blot - Anti-Cdk6 antibody [8H4] (AB54576)

Lanes 1 and 2 : Green signal from target – ab54576 observed at 37 kDa
Lanes 3 and 4 : Red signal from loading control – ab8227 observed at 42 kDa
Lanes 5 and 6 : Merged (red and green) signal

ab54576 was shown to react with CDK6 when CDK6 knockout samples were used, along with additional cross-reactive bands. Wild-type and CDK6 knockout samples were subjected to SDS-PAGE. ab54576 and ab8227 (loading control to beta actin) were diluted 1 μg/mL and 1/2000 respectively and incubated overnight at 4°C. Blots were developed with Goat anti-Mouse IgG H&L (IRDye® 800CW) preadsorbed (ab216772) and Goat Anti-Rabbit IgG H&L (IRDye® 680RD) preadsorbed (ab216777) secondary antibodies at 1/10 000 dilution for 1 h at room temperature before imaging.

This image was generated using the ascites version of the product.

Lanes 1 - 2:

Western blot - Anti-Cdk6 antibody [8H4] (ab54576) at 1 µg

Lanes 3 - 4:

Western blot - Anti-Cdk6 antibody [8H4] (ab54576) at 1/2000 dilution

Lanes 1 and 3:

Wild-type HAP1 cell lysate at 20 µg

Lanes 2 and 4:

CDK6 knockout HAP1 cell lysate at 20 µg

Predicted band size: 37 kDa

false

Western blot - Anti-Cdk6 antibody [8H4] (AB54576)
  • WB

Lab

Western blot - Anti-Cdk6 antibody [8H4] (AB54576)

Western blot : Anti-CDK6 antibody [8H4] (ab54576) staining at 1 ug/ml, shown in green; Rabbit anti-alpha Tubulin antibody [EP1332Y] (ab52866) loading control staining at 1/20000 dilution, shown in magenta. In Western blot, ab54576 was shown to bind specifically to CDK6. A band was observed at 37 kDa in wild-type HCT 116 cell lysates with no signal observed at this size in CDK6 knockout cell line. To generate this image, wild-type and CDK6 knockout HCT 116 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Mouse IgG H&L 800CW and Goat anti-Rabbit IgG H&L 680RD at 1/20000 dilution.

All lanes:

Western blot - Anti-Cdk6 antibody [8H4] (ab54576) at 1 µg/mL

Lane 1:

Wild-type HCT 116 cell lysate at 20 µg

Lane 2:

CDK6 knockout HCT 116 cell lysate at 20 µg

Lane 3:

Wild-type HeLa ab255929 cell lysate at 20 µg

Lane 4:

CDK6 knockout HeLa ab260923 cell lysate at 20 µg

Secondary

All lanes:

Goat anti-Mouse IgG H&L 800CW and Goat anti-Rabbit IgG H&L 680RD at 1/20000 dilution

Predicted band size: 37 kDa

Observed band size: 37 kDa

false

Key facts

Host species

Mouse

Clonality

Monoclonal

Clone number

8H4

Isotype

IgG1

Light chain type

kappa

Carrier free

No

Reacts with

Human

Applications

WB

applications

Immunogen

Recombinant Fragment Protein within Human CDK6 aa 1-100. The exact immunogen used to generate this antibody is proprietary information.

Q00534

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "", "WB-species-notes": "<p></p>" } } }

Product details

This product was changed from ascites to tissue culture supernatant on 5th December 2019. Lot numbers higher than GR3279055 are from tissue culture supernatant. Please note that the dilutions may need to be adjusted accordingly. If you have any questions, please do not hesitate to contact our scientific support team.

Properties and storage information

Form
Liquid
Purity
Tissue culture supernatant
Storage buffer
pH: 7.4
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Cdk6 also known as Cyclin-dependent kinase 6 is a protein kinase involved in the regulation of the cell cycle. It has a molecular weight of approximately 40 kDa. Cdk6 is expressed in various tissues including lymphoid tissues and the brain. It plays a mechanical role by phosphorylating target proteins which impacts cell cycle progression particularly during the transition from G1 phase to S phase. Cdk6 can work in conjunction with D-type cyclins to form a complex that is critical for its activity.
Biological function summary

Cdk6 functions as a regulator of the cell cycle. It participates in a complex with cyclin D to control the G1 phase progression. This activity is essential for the regulation of cell division and proliferation. The association with cyclin D allows Cdk6 to phosphorylate the retinoblastoma protein (Rb) leading to the release of E2F transcription factors that promote the expression of genes necessary for DNA synthesis.

Pathways

Cdk6 is an important component of the cell cycle control pathway. It interacts primarily with the retinoblastoma protein and Cyclin D1 in this context. The cell cycle pathway is critical for controlled cell proliferation and its dysregulation can lead to diseases like cancer. Another involved pathway is the PI3K/AKT pathway which can activate Cdk6 activity through upstream signaling events implicating Cdk6 in cellular responses to growth signals.

Cdk6 has a significant role in cancer development due to its involvement in uncontrolled cell proliferation. Its overexpression or dysregulation is often linked to cancers such as leukemia and glioblastoma. In cancer the interaction with proteins like cyclin D1 can lead to unchecked progression through the cell cycle contributing to oncogenesis. Additionally Cdk6 inhibitors are being explored as therapeutic agents in cancer treatment due to their potential to restore control over cell cycle progression.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Serine/threonine-protein kinase involved in the control of the cell cycle and differentiation; promotes G1/S transition. Phosphorylates pRB/RB1 and NPM1. Interacts with D-type G1 cyclins during interphase at G1 to form a pRB/RB1 kinase and controls the entrance into the cell cycle. Involved in initiation and maintenance of cell cycle exit during cell differentiation; prevents cell proliferation and negatively regulates cell differentiation, but is required for the proliferation of specific cell types (e.g. erythroid and hematopoietic cells). Essential for cell proliferation within the dentate gyrus of the hippocampus and the subventricular zone of the lateral ventricles. Required during thymocyte development. Promotes the production of newborn neurons, probably by modulating G1 length. Promotes, at least in astrocytes, changes in patterns of gene expression, changes in the actin cytoskeleton including loss of stress fibers, and enhanced motility during cell differentiation. Prevents myeloid differentiation by interfering with RUNX1 and reducing its transcription transactivation activity, but promotes proliferation of normal myeloid progenitors. Delays senescence. Promotes the proliferation of beta-cells in pancreatic islets of Langerhans. May play a role in the centrosome organization during the cell cycle phases (PubMed : 23918663).
See full target information CDK6

Publications (16)

Recent publications for all applications. Explore the full list and refine your search

Cancer cell 42:474-486.e12 PubMed38402610

2024

Chronic stress increases metastasis via neutrophil-mediated changes to the microenvironment.

Applications

Unspecified application

Species

Unspecified reactive species

Xue-Yan He,Yuan Gao,David Ng,Evdokia Michalopoulou,Shanu George,Jose M Adrover,Lijuan Sun,Jean Albrengues,Juliane Daßler-Plenker,Xiao Han,Ledong Wan,Xiaoli Sky Wu,Longling S Shui,Yu-Han Huang,Bodu Liu,Chang Su,David L Spector,Christopher R Vakoc,Linda Van Aelst,Mikala Egeblad

Journal of molecular cell biology 15: PubMed37791390

2023

CBX7 reprograms metabolic flux to protect against meningioma progression by modulating the USP44/c-MYC/LDHA axis.

Applications

Unspecified application

Species

Unspecified reactive species

Haixia Cheng,Lingyang Hua,Hailiang Tang,Zhongyuan Bao,Xiupeng Xu,Hongguang Zhu,Shuyang Wang,Zeyidan Jiapaer,Roma Bhatia,Ian F Dunn,Jiaojiao Deng,Daijun Wang,Shuchen Sun,Shihai Luan,Jing Ji,Qing Xie,Xinyu Yang,Ji Lei,Guoping Li,Xianli Wang,Ye Gong

Science advances 7: PubMed34362741

2021

Differential H4K16ac levels ensure a balance between quiescence and activation in hematopoietic stem cells.

Applications

Unspecified application

Species

Unspecified reactive species

Cecilia Pessoa Rodrigues,Asifa Akhtar

Science advances 6:eabb2210 PubMed32704543

2020

Increased lysosomal biomass is responsible for the resistance of triple-negative breast cancers to CDK4/6 inhibition.

Applications

Unspecified application

Species

Unspecified reactive species

Anne Fassl,Christopher Brain,Monther Abu-Remaileh,Iga Stukan,Deborah Butter,Piotr Stepien,Avery S Feit,Johann Bergholz,Wojciech Michowski,Tobias Otto,Qing Sheng,Alice Loo,Walter Michael,Ralph Tiedt,Carmine DeAngelis,Rachel Schiff,Baishan Jiang,Bojana Jovanovic,Karolina Nowak,Maria Ericsson,Michael Cameron,Nathanael Gray,Deborah Dillon,Jean J Zhao,David M Sabatini,Rinath Jeselsohn,Myles Brown,Kornelia Polyak,Piotr Sicinski

Nature communications 11:2350 PubMed32393766

2020

Acquired resistance to combined BET and CDK4/6 inhibition in triple-negative breast cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Jennifer Y Ge,Shaokun Shu,Mijung Kwon,Bojana Jovanović,Katherine Murphy,Anushree Gulvady,Anne Fassl,Anne Trinh,Yanan Kuang,Grace A Heavey,Adrienne Luoma,Cloud Paweletz,Aaron R Thorner,Kai W Wucherpfennig,Jun Qi,Myles Brown,Piotr Sicinski,Thomas O McDonald,David Pellman,Franziska Michor,Kornelia Polyak

OncoTargets and therapy 12:6733-6743 PubMed31686834

2019

Linc00467 promotes lung adenocarcinoma proliferation via sponging miR-20b-5p to activate CCND1 expression.

Applications

Unspecified application

Species

Unspecified reactive species

Hao Ding,Yuchuan Luo,Ke Hu,Pei Liu,Mengqing Xiong

Sarcoma 2019:3914232 PubMed30804704

2019

Analysis of the CDK4/6 Cell Cycle Pathway in Leiomyosarcomas as a Potential Target for Inhibition by Palbociclib.

Applications

Unspecified application

Species

Unspecified reactive species

Michael J Böhm,Ralf Marienfeld,Daniela Jäger,Kevin Mellert,Adrian von Witzleben,Silke Brüderlein,Mathias Wittau,Alexandra von Baer,Markus Schultheiss,Regine Mayer-Steinacker,Frank G Rücker,Peter Möller,Lars Bullinger,Thomas F E Barth

Cellular physiology and biochemistry : internation 51:909-923 PubMed30466085

2018

CDK6 and miR-320c Co-Regulate Chondrocyte Catabolism Through NF-κB Signaling Pathways.

Applications

Unspecified application

Species

Unspecified reactive species

Hao Sun,Zhiyu Huang,Peihui Wu,Zongkun Chang,Weiming Liao,Zhiqi Zhang

Developmental cell 43:449-462.e5 PubMed29103955

2017

Cell-Cycle Proteins Control Production of Neutrophil Extracellular Traps.

Applications

Unspecified application

Species

Unspecified reactive species

Borko Amulic,Sebastian Lorenz Knackstedt,Ulrike Abu Abed,Nikolaus Deigendesch,Christopher J Harbort,Brian E Caffrey,Volker Brinkmann,Frank L Heppner,Philip W Hinds,Arturo Zychlinsky

Oncogene 36:5861-5873 PubMed28628119

2017

Differential expression of miR16 in glioblastoma and glioblastoma stem cells: their correlation with proliferation, differentiation, metastasis and prognosis.

Applications

Unspecified application

Species

Unspecified reactive species

R Tian,J Wang,H Yan,J Wu,Q Xu,X Zhan,Z Gui,M Ding,J He
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com